Epstein-Barr virus, 9.4 T MRI and phosphodiesterase inhibitors in multiple sclerosis

Affiliations

Comment

Michael Strupp. J Neurol. 2010 May.

. 2010 May;257(5):860-2.

doi: 10.1007/s00415-010-5571-y.

¹ Department of Neurology, Ludwig Maximilian University, Klinikum Grosshadern, Marchioninstr 15, 81377 Munich, Germany. Michael.strupp@med.uni-muenchen.de

No abstract available

Comment on

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH. Schmierer K, et al. Brain. 2010 Mar;133(Pt 3):858-67. doi: 10.1093/brain/awp335. Epub 2010 Jan 31. Brain. 2010. PMID: 20123726
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R; MN166-001 Investigators. Barkhof F, et al. Neurology. 2010 Mar 30;74(13):1033-40. doi: 10.1212/WNL.0b013e3181d7d651. Epub 2010 Mar 3. Neurology. 2010. PMID: 20200338 Clinical Trial.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL. Sargsyan SA, et al. Neurology. 2010 Apr 6;74(14):1127-35. doi: 10.1212/WNL.0b013e3181d865a1. Epub 2010 Mar 10. Neurology. 2010. PMID: 20220124 Free PMC article.